Research ArticleArticle
Open Access
Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol
Megan E.B. Clowse, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper and Uma Mahadevan
The Journal of Rheumatology December 2015, 42 (12) 2270-2278; DOI: https://doi.org/10.3899/jrheum.140189
Megan E.B. Clowse
From Duke University Medical Center, Durham; Union Chimique Belge (UCB) Pharma, Raleigh, North Carolina; Atlanta Gastroenterology Associates, Atlanta,
Georgia; Baylor Research Institute and Baylor University Medical Center, Dallas, Texas; University of California San Francisco (UCSF) Center for Colitis and Crohn’s Disease, San Francisco, California,
USA; Department of Rheumatology, Immunology and Allergology, Inselspital, University of Bern, Bern,
Switzerland; UCB Pharma, Brussels,
Belgium.
Douglas C. Wolf
Frauke Förger
John J. Cush
Amanda Golembesky
Laura Shaughnessy
Dirk De Cuyper
In this issue
The Journal of Rheumatology
Vol. 42, Issue 12
1 Dec 2015
Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol
Megan E.B. Clowse, Douglas C. Wolf, Frauke Förger, John J. Cush, Amanda Golembesky, Laura Shaughnessy, Dirk De Cuyper, Uma Mahadevan
The Journal of Rheumatology Dec 2015, 42 (12) 2270-2278; DOI: 10.3899/jrheum.140189